BioCryst Pharmaceuticals, Inc.’s Post

We recently launched the report “The power of partnership: shared decision making in HAE” in the United Kingdom. In collaboration with HAE UK, we carried out in-depth research into the use of shared decision making (SDM) in the management of hereditary angioedema (HAE), a potentially life-threatening rare disease. The report summarizes our findings and recommendations. Learn more: https://lnkd.in/ejhzvhwG

  • No alternative text description for this image

Good to know!

Like
Reply
Diane Ramsey-Paige

Sr. Nurse Advocate Manager, Global Patient Advocacy BioCryst Pharmaceuticals

4w

Fantastic work by Gemma, George, Luke, and team!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics